PMID- 25359626 OWN - NLM STAT- MEDLINE DCOM- 20160204 LR - 20220330 IS - 1297-9716 (Electronic) IS - 0928-4249 (Print) IS - 0928-4249 (Linking) VI - 45 IP - 1 DP - 2014 Oct 31 TI - Bovine herpesvirus glycoprotein D: a review of its structural characteristics and applications in vaccinology. PG - 111 LID - 10.1186/s13567-014-0111-x [doi] LID - 111 AB - The viral envelope glycoprotein D from bovine herpesviruses 1 and 5 (BoHV-1 and -5), two important pathogens of cattle, is a major component of the virion and plays a critical role in the pathogenesis of herpesviruses. Glycoprotein D is essential for virus penetration into permissive cells and thus is a major target for virus neutralizing antibodies during infection. In view of its role in the induction of protective immunity, gD has been tested in new vaccine development strategies against both viruses. Subunit, DNA and vectored vaccine candidates have been developed using this glycoprotein as the primary antigen, demonstrating that gD has the capacity to induce robust virus neutralizing antibodies and strong cell-mediated immune responses, as well as protection from clinical symptoms, in target species. This review highlights the structural and functional characteristics of BoHV-1, BoHV-5 and where appropriate, Human herpesvirus gD, as well as its role in viral entry and interactions with host cell receptors. Furthermore, the interactions of gD with the host immune system are discussed. Finally, the application of this glycoprotein in new vaccine design is reviewed, taking its structural and functional characteristics into consideration. FAU - Alves Dummer, Luana AU - Alves Dummer L AD - Laboratorio de Bacteriologia, Nucleo de Biotecnologia, Centro de Desenvolvimento Tecnologico, Universidade Federal de Pelotas, Pelotas, Rio Grande do Sul, 96010-900, Brazil. dummer@gmail.com. FAU - Pereira Leivas Leite, Fabio AU - Pereira Leivas Leite F AD - Laboratorio de Bacteriologia, Nucleo de Biotecnologia, Centro de Desenvolvimento Tecnologico, Universidade Federal de Pelotas, Pelotas, Rio Grande do Sul, 96010-900, Brazil. fabio_leite@ufpel.edu.br. FAU - van Drunen Littel-van den Hurk, Sylvia AU - van Drunen Littel-van den Hurk S AD - Microbiology and Immunology, College of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, S7N 5E3, Canada. sylvia.vandenhurk@usask.ca. AD - VIDO-Intervac, University of Saskatchewan, Saskatoon, Saskatchewan, S7N 5E3, Canada. sylvia.vandenhurk@usask.ca. LA - eng PT - Journal Article PT - Review DEP - 20141031 PL - England TA - Vet Res JT - Veterinary research JID - 9309551 RN - 0 (Viral Envelope Proteins) RN - 0 (Viral Vaccines) SB - IM MH - Amino Acid Sequence MH - Animals MH - Herpesvirus 1, Bovine/immunology/*physiology MH - Herpesvirus 1, Human/immunology/*physiology MH - Herpesvirus 2, Human/immunology/*physiology MH - Herpesvirus 5, Bovine/immunology/*physiology MH - Humans MH - Viral Envelope Proteins/chemistry/*genetics MH - Viral Vaccines/*immunology PMC - PMC4252008 EDAT- 2014/11/02 06:00 MHDA- 2016/02/05 06:00 PMCR- 2014/10/31 CRDT- 2014/11/01 06:00 PHST- 2014/07/06 00:00 [received] PHST- 2014/10/09 00:00 [accepted] PHST- 2014/11/01 06:00 [entrez] PHST- 2014/11/02 06:00 [pubmed] PHST- 2016/02/05 06:00 [medline] PHST- 2014/10/31 00:00 [pmc-release] AID - s13567-014-0111-x [pii] AID - 111 [pii] AID - 10.1186/s13567-014-0111-x [doi] PST - epublish SO - Vet Res. 2014 Oct 31;45(1):111. doi: 10.1186/s13567-014-0111-x.